Literature DB >> 24576629

Using population screening for recruitment of young adults engaged in illicit drug use: methodological issues and sampling outcomes.

Andrew Smirnov1, Robert Kemp2, Helene Wells3, Margot Legosz3, Jake M Najman4.   

Abstract

Social stigma, legal sanctions and the associated lack of sampling frames create barriers to the probabilistic sampling of those engaged in a variety of behaviour, including illicit drug use. We used a novel sampling approach to recruit respondents into a longitudinal study examining amphetamine-type stimulant use. A young adult population was screened for lifetime drug use to create a sampling frame of amphetamine-type stimulant users and non-users. We posted 12,118 screening questionnaires to a random selection of young adults listed on the electoral roll for Brisbane and the Gold Coast, Australia (N=107,275). Using a small pre-paid incentive and intensive telephone and postal reminders we attained a screening response rate of 49.9%. Eligible amphetamine-type stimulant users (used ecstasy or methamphetamine⩾3 times in past 12 months) and non-users (never used ecstasy or methamphetamine) were identified by screening responses. About two-thirds of each selected group took part in the longitudinal study. Comparisons with large-scale population survey data suggest the sample was broadly representative of young adult amphetamine-type stimulant users in Australia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ecstasy (MDMA); Illicit drug use; Methamphetamine; Population screening; Probabilistic sampling

Mesh:

Substances:

Year:  2014        PMID: 24576629     DOI: 10.1016/j.ssresearch.2014.01.003

Source DB:  PubMed          Journal:  Soc Sci Res        ISSN: 0049-089X


  1 in total

1.  Injecting drug use opportunities and reasons for choosing not to inject: A population-based study of Australian young adults who use stimulants.

Authors:  Luke Edward Casey; Davoud Pourmarzi; Ellen Leslie Wessel; Robert Kemp; Andrew Smirnov
Journal:  Drug Alcohol Rev       Date:  2022-02-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.